Neuroprotection of posttreatment with risperidone, an atypical antipsychotic drug, in rat and gerbil models of ischemic stroke and the maintenance of antioxidants in a gerbil model of ischemic stroke

Journal of Neuroscience Research

Volumn 92, Issue 6, 2014, Pages 795-807

  Yan, Bing Chun ^a   Park, Joon Ha ^b   Ahn, Ji Hyeon ^b   Kim, In Hye ^b   Park, Ok Kyu ^c   Lee, Jae Chul ^b   Yoo, Ki Yeon ^d   Choi, Jung Hoon ^b   Lee, Choong Hyun ^e   Hwang, In Koo ^f   Park, Jeong Ho ^g   Her, Song ^c   Kim, Jin Su ^h   Shin, Hyung Cheul ⁱ   Cho, Jun Hwi ^b   Kim, Young Myeong ^b   Kwon, Seung Hae ^c   Won, Moo Ho ^b  

^a YANGZHOU UNIVERSITY   (China)

^b Kangwon National University   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d Gangneung Wonju National University   (South Korea)

^e Dankook University   (South Korea)

^f Seoul National University   (South Korea)

^g Hanbat National University   (South Korea)

^h Korea Institute of Radiation and Medical Science   (South Korea)

ⁱ Hallym University   (South Korea)

Author keywords

Microglial activation; Neuroprotection; Oxidative stress; Risperidone; Transient cerebral ischemia

Indexed keywords

ANTIOXIDANT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; FLUORODEOXYGLUCOSE F 18; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; RISPERIDONE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CELL ACTIVATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GERBIL MODEL; HIPPOCAMPAL CA1 REGION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PET SCANNER; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STRATUM PYRAMIDALE; TREATMENT DURATION; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GERBIL; METABOLISM; NERVE CELL; PATHOLOGY; SPRAGUE DAWLEY RAT; STROKE; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GERBILLINAE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE; STROKE;

EID: 84897575593     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23360     Document Type: Article

References (53)

1. Altinkilic S, Naziroglu M, Uguz AC, Ozcankaya R. 2010. Fish oil and antipsychotic drug risperidone modulate oxidative stress in PC12 cell membranes through regulation of cytosolic calcium ion release and antioxidant system. J Membr Biol 235:211-218.
2. Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM. 2003. Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res 71:127-131.
3. Bai O, Zhang H, Li XM. 2004. Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 1010:81-86.
4. Bardgett ME, Franks-Henry JM, Colemire KR, Juneau KR, Stevens RM, Marczinski CA, Griffith MS. 2013. Adult rats treated with risperidone during development are hyperactive. Exp Clin Psychopharmacol 21:259-267.
5. Bastianetto S, Danik M, Mennicken F, Williams S, Quirion R. 2006. Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. BMC Neurosci 7:28.
6. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. 1996. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 27:1616-1622; discussion 1623.
7. Bennouna M, Greene VB, Defranoux L. 2005. Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury. J Clin Psychopharmacol 25:505-507.
8. Brugue E, Vieta E. 2007. Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications. Prog Neuropsychopharmacol Biol Psychiatry 31:275-282.
9. Castellano O, Arji M, Sancho C, Carro J, Riolobos AS, Molina V, Gomez-Nieto R, de Anchieta de Castro EHJ Jr, Herrero-Turrion MJ, Lopez DE. 2013. Chronic administration of risperidone in a rat model of schizophrenia: a behavioural, morphological and molecular study. Behav Brain Res 242:178-190.
10. Chan PH. 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2-14.
11. Cho JH, Yan BC, Lee YJ, Park JH, Ahn JH, Kim IH, Lee JC, Kim YM, Lee B, Won MH. 2013. Reduced beta-catenin expression in the hippocampal CA1 region following transient cerebral ischemia in the gerbil. Neurochem Res 38:1045-1054.
12. Corbett D, Larsen J, Langdon KD. 2008. Diazepam delays the death of hippocampal CA1 neurons following global ischemia. Exp Neurol 214:309-314.
13. Costa C, Tozzi A, Luchetti E, Siliquini S, Belcastro V, Tantucci M, Picconi B, Ientile R, Calabresi P, Pisani F. 2010. Electrophysiological actions of zonisamide on striatal neurons: selective neuroprotection against complex I mitochondrial dysfunction. Exp Neurol 221:217-224.
14. Crack PJ, Taylor JM, de Haan JB, Kola I, Hertzog P, Iannello RC. 2003. Glutathione peroxidase-1 contributes to the neuroprotection seen in the superoxide dismutase-1 transgenic mouse in response to ischemia/reperfusion injury. J Cereb Blood Flow Metab 23:19-22.
15. Endres M, Heuschmann PU, Laufs U, Hakim AM. 2011. Primary prevention of stroke: blood pressure, lipids, and heart failure. Eur Heart J 32:545-552.
16. Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP. 2003. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot Essent Fatty Acids 69:393-399.
17. Ghosh A, Sarkar S, Mandal AK, Das N. 2013. Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats. PLoS One 8:e57735.
18. Giulivi C, Boveris A, Cadenas E. 1995. Hydroxyl radical generation during mitochondrial electron transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA. Arch Biochem Biophys 316:909-916.
19. He J, Kong J, Tan QR, Li XM. 2009. Neuroprotective effect of atypical antipsychotics in cognitive and noncognitive behavioral impairment in animal models. Cell Adhes Migr 3:129-137.
20. Hsieh CH, Kuo JW, Lee YJ, Chang CW, Gelovani JG, Liu RS. 2009. Construction of mutant TKGFP for real-time imaging of temporal dynamics of HIF-1 signal transduction activity mediated by hypoxia and reoxygenation in tumors in living mice. J Nucl Med 50:2049-2057.
21. Jung JE, Kim GS, Narasimhan P, Song YS, Chan PH. 2009. Regulation of Mn-superoxide dismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia. J Neurosci 29:7003-7014.
22. Kang GH, Yan BC, Cho GS, Kim WK, Lee CH, Cho JH, Kim M, Kang IJ, Won MH, Lee JC. 2012. Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration. J Neurol Sci 318:25-30.
23. Kato R, Sato J, Suzuki H. 2005. [Anesthesia for cesarean section in a parturient taking risperidone and haloperidol]. Masui 54:301-303.
24. Kato T, Monji A, Hashioka S, Kanba S. 2007. Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res 92:108-115.
25. Keefe RS, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA. 2007. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 164:1061-1071.
26. Keilhoff G, Grecksch G, Bernstein HG, Roskoden T, Becker A. 2010. Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. Eur Arch Psychiatry Clin Neurosci 260:151-162.
27. Kim do H, Li H, Yoo KY, Lee BH, Hwang IK, Won MH. 2007. Effects of fluoxetine on ischemic cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia. Exp Neurol 204:748-758.
28. Kim GW, Lewen A, Copin J, Watson BD, Chan PH. 2001. The cytosolic antioxidant, copper/zinc superoxide dismutase, attenuates blood-brain barrier disruption and oxidative cellular injury after photothrombotic cortical ischemia in mice. Neuroscience 105:1007-1018.
29. Kim IH, Yan BC, Park JH, Yeun GH, Yim Y, Ahn JH, Lee JC, Hwang IK, Cho JH, Kim YM, Lee YL, Won MH. 2013. Neuroprotection of a novel synthetic caffeic acid-syringic acid hybrid compound against experimentally induced transient cerebral ischemic damage. Planta Med 79:313-321.
30. Lee CH, Park JH, Choi JH, Yoo KY, Ryu PD, Won MH. 2011a. Heat shock protein 90 and its cochaperone, p23, are markedly increased in the aged gerbil hippocampus. Exp Gerontol 46:768-772.
31. Lee CH, Park JH, Yoo KY, Choi JH, Hwang IK, Ryu PD, Kim DH, Kwon YG, Kim YM, Won MH. 2011b. Pre- and posttreatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress. Exp Neurol 229:450-459.
32. Lee EJ, Chen HY, Hung YC, Chen TY, Lee MY, Yu SC, Chen YH, Chuang IC, Wu TS. 2009. Therapeutic window for cinnamophilin following oxygen-glucose deprivation and transient focal cerebral ischemia. Exp Neurol 217:74-83.
33. Leysen JE, Gommeren W, Eens A, de Chaffoy de Courcelles D, Stoof JC, Janssen PA. 1988. Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 247:661-670.
34. Li XM, Chlan-Fourney J, Juorio AV, Bennett VL, Shrikhande S, Keegan DL, Qi J, Boulton AA. 1999. Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor. J Neurosci Res 56:72-75.
35. Megens AA, Awouters FH, Schotte A, Meert TF, Dugovic C, Niemegeers CJ, Leysen JE. 1994. Survey on the pharmacodynamics of the new antipsychotic risperidone. Psychopharmacology 114:9-23.
36. Moro MA, Almeida A, Bolanos JP, Lizasoain I. 2005. Mitochondrial respiratory chain and free radical generation in stroke. Free Radic Biol Med 39:1291-1304.
37. Muir KW, Tyrrell P, Sattar N, Warburton E. 2007. Inflammation and ischaemic stroke. Curr Opin Neurol 20:334-342.
38. Pae CU, Lim HK, Peindl K, Ajwani N, Serretti A, Patkar AA, Lee C. 2008. The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Clin Psychopharmacol 23:1-8.
39. Picada JN, Dos Santos Bde J, Celso F, Monteiro JD, Da Rosa KM, Camacho LR, Vieira LR, Freitas TM, Da Silva TG, Pontes VM, Pereira P. 2011. Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice. Acta Pharmacol Sin 32:1225-1232.
40. Quincozes-Santos A, Abib RT, Leite MC, Bobermin D, Bambini-Junior V, Goncalves CA, Riesgo R, Gottfried C. 2008. Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells. Mol Cell Biochem 314:59-63.
41. Radi R, Sims S, Cassina A, Turrens JF. 1993. Roles of catalase and cytochrome c in hydroperoxide-dependent lipid peroxidation and chemiluminescence in rat heart and kidney mitochondria. Free Radic Biol Med 15:653-659.
42. Shin JY, Choi NK, Jung SY, Lee J, Kwon JS, Park BJ. 2013. Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study. J Psychopharmacol 27:638-644.
43. Stoll G, Jander S, Schroeter M. 1998. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56:149-171.
44. Sugawara T, Lewen A, Noshita N, Gasche Y, Chan PH. 2002. Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats. J Neurotrauma 19:85-98.
45. Wakade CG, Mahadik SP, Waller JL, Chiu FC. 2002. Atypical neuroleptics stimulate neurogenesis in adult rat brain. J Neurosci Res 69:72-79.
46. Yan BC, Park JH, Lee CH, Yoo KY, Choi JH, Lee YJ, Cho JH, Baek YY, Kim YM, Won MH. 2011. Increases of antioxidants are related to more delayed neuronal death in the hippocampal CA1 region of the young gerbil induced by transient cerebral ischemia. Brain Res 1425:142-154.
47. Yan BC, Park JH, Shin BN, Ahn JH, Kim IH, Lee JC, Yoo KY, Hwang IK, Choi JH, Lee YL, Suh HW, Jun JG, Kwon YG, Kim YM, Kwon SH, Her S, Kim JS, Hyun BH, Kim CK, Cho JH, Lee CH, Won MH. 2013. Neuroprotective effect of a new synthetic aspirin-decursinol adduct in experimental animal models of ischemic stroke. PLoS One 8:e74886.
48. Yilmaz HR, Uz E, Yucel N, Altuntas I, Ozcelik N. 2004. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol 18:234-238.
49. Yoon DK, Yoo KY, Hwang IK, Lee JJ, Kim JH, Kang TC, Won MH. 2006. Comparative study on Cu, Zn-SOD immunoreactivity and protein levels in the adult and aged hippocampal CA1 region after ischemia-reperfusion. Brain Res 1092:214-219.
50. Yu H, Zhang ZL, Chen J, Pei A, Hua F, Qian X, He J, Liu CF, Xu X. 2012. Carvacrol, a food-additive, provides neuroprotection on focal cerebral ischemia/reperfusion injury in mice. PLoS One 7:e33584.
51. Yulug B, Yildiz A, Guzel O, Kilic E, Schabitz WR. 2006. Risperidone attenuates brain damage after focal cerebral ischemia in vivo. Brain Res Bull 69:656-659.
52. Zheng YJ, Wang XR, Chen HZ, Wu XJ, Zhao YH, Su DS. 2012. Protective effects of the delta opioid peptide [D-Ala2, D-Leu5]enkephalin in an ex vivo model of ischemia/reperfusion in brain slices. CNS Neurosci Ther 18:762-766.
53. Zhu BG, Sun Y, Sun ZQ, Yang G, Zhou CH, Zhu RS. 2012. Optimal dosages of fluoxetine in the treatment of hypoxic brain injury induced by 3-nitropropionic acid: implications for the adjunctive treatment of patients after acute ischemic stroke. CNS Neurosci Ther 18:530-535.